Research Summary
Ranibizumab is a monoclonal antibody drug that is used for the treatment of certain eye conditions, particularly neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion, and diabetic macular edema. Marketed under the trade name Lucentis, ranibizumab works by inhibiting vascular endothelial growth factor (VEGF), a protein that plays a key role in the formation of abnormal blood vessels in the eye. By blocking VEGF, ranibizumab helps reduce the growth of these abnormal blood vessels, preventing leakage and fluid accumulation in the macula. This treatment is administered through intravitreal injections directly into the eye. Ranibizumab has demonstrated efficacy in slowing disease progression and improving visual acuity in patients with certain retinal conditions, making it an important therapeutic option in ophthalmology.
According to DIResearch's in-depth investigation and research, the global Ranibizumab market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Ranibizumab include Roche, Novartis etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Ranibizumab. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ranibizumab market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Ranibizumab market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ranibizumab industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Ranibizumab Include:
Roche
Novartis
Ranibizumab Product Segment Include:
Glass Vial
Prefilled Syringe
Ranibizumab Product Application Include:
Wet AMD
Complications of Diabetes
RVO
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Ranibizumab Industry PESTEL Analysis
Chapter 3: Global Ranibizumab Industry Porter's Five Forces Analysis
Chapter 4: Global Ranibizumab Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Ranibizumab Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Ranibizumab Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Ranibizumab Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Ranibizumab Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Ranibizumab Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Ranibizumab Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Ranibizumab Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Ranibizumab Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Ranibizumab Market Overview 1.1 Product Definition and Statistical Scope 1.2 Ranibizumab Product by Type 1.2.1 Global Ranibizumab Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Glass Vial 1.2.3 Prefilled Syringe 1.3 Ranibizumab Product by Application 1.3.1 Global Ranibizumab Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Wet AMD 1.3.3 Complications of Diabetes 1.3.4 RVO 1.3.5 Others 1.4 Global Ranibizumab Market Revenue and Sales Analysis 1.4.1 Global Ranibizumab Market Size Analysis (2019-2030) 1.4.2 Global Ranibizumab Market Sales Analysis (2019-2030) 1.4.3 Global Ranibizumab Market Sales Price Trend Analysis (2019-2030) 1.5 Ranibizumab Market Development Status and Trends 1.5.1 Ranibizumab Industry Development Status Analysis 1.5.2 Ranibizumab Industry Development Trends Analysis 2 Ranibizumab Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Ranibizumab Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Ranibizumab Market Analysis by Regions 4.1 Ranibizumab Overall Market: 2023 VS 2024 VS 2030 4.2 Global Ranibizumab Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Ranibizumab Revenue and Market Share by Region (2019-2024) 4.2.2 Global Ranibizumab Revenue Forecast by Region (2025-2030) 4.3 Global Ranibizumab Sales and Forecast Analysis (2019-2030) 4.3.1 Global Ranibizumab Sales and Market Share by Region (2019-2024) 4.3.2 Global Ranibizumab Sales Forecast by Region (2025-2030) 4.4 Global Ranibizumab Sales Price Trend Analysis (2019-2030) 5 Global Ranibizumab Market Size by Type and Application 5.1 Global Ranibizumab Market Size by Type 5.1.1 Global Ranibizumab Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Ranibizumab Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Ranibizumab Market Size by Application 5.2.1 Global Ranibizumab Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Ranibizumab Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Ranibizumab Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Ranibizumab Market Size by Type 6.3.1 North America Ranibizumab Sales by Type (2019-2030) 6.3.2 North America Ranibizumab Revenue by Type (2019-2030) 6.4 North America Ranibizumab Market Size by Application 6.4.1 North America Ranibizumab Sales by Application (2019-2030) 6.4.2 North America Ranibizumab Revenue by Application (2019-2030) 6.5 North America Ranibizumab Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Ranibizumab Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Ranibizumab Market Size by Type 7.3.1 Europe Ranibizumab Sales by Type (2019-2030) 7.3.2 Europe Ranibizumab Revenue by Type (2019-2030) 7.4 Europe Ranibizumab Market Size by Application 7.4.1 Europe Ranibizumab Sales by Application (2019-2030) 7.4.2 ? Europe Ranibizumab Revenue by Application (2019-2030) 7.5 Europe Ranibizumab Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Ranibizumab Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Ranibizumab Market Size by Type 8.3.1 China Ranibizumab Sales by Type (2019-2030) 8.3.2 China Ranibizumab Revenue by Type (2019-2030) 8.4 China Ranibizumab Market Size by Application 8.4.1 China Ranibizumab Sales by Application (2019-2030) 8.4.2 China Ranibizumab Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Ranibizumab Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Ranibizumab Market Size by Type 9.3.1 APAC (excl. China) Ranibizumab Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Ranibizumab Revenue by Type (2019-2030) 9.4 APAC (excl. China) Ranibizumab Market Size by Application 9.4.1 APAC (excl. China) Ranibizumab Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Ranibizumab Revenue by Application (2019-2030) 9.5 APAC (excl. China) Ranibizumab Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Ranibizumab Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Ranibizumab Market Size by Type 10.3.1 Latin America Ranibizumab Sales by Type (2019-2030) 10.3.2 Latin America Ranibizumab Revenue by Type (2019-2030) 10.4 Latin America Ranibizumab Market Size by Application 10.4.1 Latin America Ranibizumab Sales by Application (2019-2030) 10.4.2 Latin America Ranibizumab Revenue by Application (2019-2030) 10.5 Latin America Ranibizumab Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Ranibizumab Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Ranibizumab Market Size by Type 11.3.1 Middle East & Africa Ranibizumab Sales by Type (2019-2030) 11.3.2 Middle East & Africa Ranibizumab Revenue by Type (2019-2030) 11.4 Middle East & Africa Ranibizumab Market Size by Application 11.4.1 Middle East & Africa Ranibizumab Sales by Application (2019-2030) 11.4.2 Middle East & Africa Ranibizumab Revenue by Application (2019-2030) 11.5 Middle East & Africa Ranibizumab Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Ranibizumab Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Ranibizumab Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Ranibizumab Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Ranibizumab Average Sales Price by Manufacturers (2020-2024) 12.2 Ranibizumab Competitive Landscape Analysis and Market Dynamic 12.2.1 Ranibizumab Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Roche 13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Roche Ranibizumab Product Portfolio 13.1.3 Roche Ranibizumab Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Novartis 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Novartis Ranibizumab Product Portfolio 13.2.3 Novartis Ranibizumab Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Ranibizumab Industry Chain Analysis 14.2 Ranibizumab Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Ranibizumab Typical Downstream Customers 14.4 Ranibizumab Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support